Glucose Control Outcomes With a Long-Term Implantable CGM System in Type 1 Diabetes Prone to Hypoglycemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring (CGM) system in adults with type 1 diabetes prone to hypoglycemia. France Adoption randomized clinical trial
Diabetes Obes Metab 2022 Jan 04;[EPub Ahead of Print], E Renard, JP Riveline, H Hanaire, B GuerciFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.